Ads
related to: biosciences
Search results
HC Wainwright Analysts Cut Earnings Estimates for Spruce Biosciences, Inc. (NASDAQ:SPRB)
ETF DAILY NEWS· 9 hours agoSpruce Biosciences, Inc. (NASDAQ:SPRB – Free Report) – Equities researchers at HC Wainwright cut their Q2 2024 EPS estimates for Spruce Biosciences in a ...
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Up 7.0% in April
ETF DAILY NEWS· 10 hours agoAura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest ...
Amalgamated Bank Has $673,000 Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
ETF DAILY NEWS· 6 hours agoAmalgamated Bank lowered its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.2% during the fourth quarter, according to its most recent Form 13F filing ...
Aptose Biosciences (NASDAQ:APTO) Price Target Cut to $6.00
ETF DAILY NEWS· 7 hours agoAptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) had its price target cut by research analysts at Canaccord Genuity Group from $15.00 to $6.00 in a research note ...
We Think Cogent Biosciences (NASDAQ:COGT) Can Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 5 days agoHaving said that, unprofitable companies are risky because they could potentially burn through all...
Earnings call: Cytek Biosciences outlines robust Q1 growth, eyes expansion
Investing.com· 5 days agoCytek Biosciences (CTKB) reported a solid start to 2024 with its first-quarter earnings showcasing a...
Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
Zacks via Yahoo Finance· 20 hours agoArcadia Biosciences RKDA announced that it inked a deal with Above Food Corp. to sell its GoodWheat...
Analysts Set Expectations for Spruce Biosciences, Inc.’s Q2 2024 Earnings (NASDAQ:SPRB)
ETF DAILY NEWS· 1 day agoSpruce Biosciences, Inc. (NASDAQ:SPRB – Free Report) – Equities researchers at Leerink Partnrs cut their Q2 2024 earnings per share estimates for shares of Spruce
Coherus BioSciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 7 days agoCoherus BioSciences (NASDAQ:CHRS) First Quarter 2024 Results Key Financial Results Revenue: US$77.1m...
Aptose Biosciences Inc. (NASDAQ:APTO) Receives Consensus Rating of “Buy” from Brokerages
ETF DAILY NEWS· 1 day agoAptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) has received a consensus recommendation of “Buy” from the six ratings firms that are presently covering the ...
Ads
related to: biosciences